A 'Willful' Foe | GenomeWeb

A 'Willful' Foe

Premium

For a while, scientists have been basing their cancer research on the idea that a single cell accumulated gene mutations and develops into a malignant tumor. However, this article in The New York Times says that "cancer appears to be even more willful and calculating than previously imagined." Researchers are now studying microRNAs interfere with communication signals between cells and how the microbiome — all those microbes that live in and on the body — can influence how host cells act.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.